2019
DOI: 10.1002/jia2.25221
|View full text |Cite
|
Sign up to set email alerts
|

Dynamics in HIV‐DNA levels over time in HIV controllers

Abstract: Introduction HIV controllers (HIC) maintain viraemia at low levels without antiretroviral treatment and have small HIV reservoirs. Nevertheless, they are heterogeneous regarding their risk of infection progression. The study of reservoirs can help elucidate this control. This study aimed to explore the factors implicated in the pathogenesis of HIV infection that are potentially associated with HIV reservoirs and their dynamics in HIC.MethodsIndividuals living with HIV included in the ANRS‐CODEX cohort with at … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7

Relationship

5
2

Authors

Journals

citations
Cited by 23 publications
(23 citation statements)
references
References 37 publications
2
21
0
Order By: Relevance
“…We have also observed a negative slope for the HIV DNA load in some controllers (56), which further supports lack of a need for treatment. These results again emphasize the heterogeneity of the controller population.…”
Section: Should We Prescribe Art To All Controllers?supporting
confidence: 71%
“…We have also observed a negative slope for the HIV DNA load in some controllers (56), which further supports lack of a need for treatment. These results again emphasize the heterogeneity of the controller population.…”
Section: Should We Prescribe Art To All Controllers?supporting
confidence: 71%
“…Total cell-associated HIV-DNA in blood and CD4+T cell subsets was quantified using ultrasensitive real-time PCR (Biocentric, France) [18][19][20][21]. The entire HIV-DNA extract was tested using two to four PCRs.…”
Section: Study Populationmentioning
confidence: 99%
“…That heterogeneity also reflects that no single mechanism is responsible for controlling viral replication. In fact, recent findings have identified persistent controllers (PCs), compared to subjects who eventually lose viral control, as subjects with low viral diversity, low HIV-DNA levels, decreased immune activation and proinflammatory cytokine levels, efficient high Gag-specific T-cell polyfunctionality and a proteomic profile characterized by lower levels of inflammation, transendothelial migration and coagulation [[12], [13], [14], [15]]. PCs may help to define the right model of functional cure and may be a good example for the design of eradication strategies and HIV vaccine development.…”
Section: Introductionmentioning
confidence: 99%